This hormone signals to the brain that youre full, helping to reduce hunger and cravings
Results at Week 30 in a Trial of OZEMPIC in Adult Patients with Type 2 Diabetes Mellitus in Combination with Basal Insulin with or without Metformin aThe intent-to-treat population includes all randomized and exposed patients
It is still uncertain how long term health outcomes are improved in patients with obesity alone, and if previously observed effects are simply mediated by enhanced glycemic control
Some people with prediabetes, type 2 diabetes, or obesity may release less GLP-1 peptide hormone than they need
However, absorption decreases significantly as doses increase, and individuals with compromised gut health may absorb only 1-2%
doi:10.1097/HC9.0000000000000488 Sheka AC, Adeyi O, Thompson J, et al